Dario signs two employers for cardiometabolic suite with integrated glp-1 solution

Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health new york , april 18, 2024 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two employers beginning in the second quarter of 2024. the employers, a national supply chain company and a regional education organization, selected dario's cardiometabolic suite to help improve outcomes for employees with cardiometabolic health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including support for individuals taking a glp-1 medication.
DRIO Ratings Summary
DRIO Quant Ranking